STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

NATIONAL PEDIATRIC CANCER FOUNDATION INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
NATIONAL PEDIATRIC CANCER FOUNDATION INC (EIN 59-3097333)
Tax period
2024-07-01 to 2025-06-30
Filed
2025-10-17
IRS object ID
202532909349300108
Schema version
2024v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-10-17T07:41:23-05:00ReturnTs
Tax Period End2025-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN593040705PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1RIVERO GORDIMER & COMPANY PABusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1201 N FRANKLIN ST SUITE 2200AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33602ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN593097333EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL PEDIATRIC CANCERBusinessNameLine1Txt
Business Name Line2FOUNDATION INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlNATIBusinessNameControlTxt
Phone8132690955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15550 WEST EXECUTIVE DRIVE SUITE 20AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33609ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonDAVID FRAZERPersonNm
Person TitleCHIEF EXECUTIVE OFFICERPersonTitleTxt
Phone8132690955PhoneNum
Signature2025-10-09SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonSAM A LAZZARAPreparerPersonNm
PTINP01342929PTIN
Phone8138757774PhoneNum
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerDAVID FRAZERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line15550 WEST EXECUTIVE DRIVE SUITE 200AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33609ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$7,238,881GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.NATIONALPCF.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1991FormationYr
Legal Domicile StateFLLegalDomicileStateCd
Activity Or MissionTHE NPCF IS DEDICATED TO FUNDING RESEARCH TO ELIMINATE CHILDHOOD CANCER.ActivityOrMissionDesc
Voting Members Governing Body22VotingMembersGoverningBodyCnt
Voting Members Independent22VotingMembersIndependentCnt
Total Employee21TotalEmployeeCnt
Total Volunteers300TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$4,516,155PYContributionsGrantsAmt
CY Contributions Grants$4,219,467CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$161,711PYInvestmentIncomeAmt
CY Investment Income$87,081CYInvestmentIncomeAmt
PY Other Revenue$332,222PYOtherRevenueAmt
CY Other Revenue$143,421CYOtherRevenueAmt
PY Total Revenue$5,010,088PYTotalRevenueAmt
CY Total Revenue$4,449,969CYTotalRevenueAmt
PY Grants And Similar Paid$2,820,170PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$3,441,620CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,589,140PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,685,577CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$356,020CYTotalFundraisingExpenseAmt
PY Other Expenses$665,731PYOtherExpensesAmt
CY Other Expenses$595,853CYOtherExpensesAmt
PY Total Expenses$5,075,041PYTotalExpensesAmt
CY Total Expenses$5,723,050CYTotalExpensesAmt
PY Revenues Less Expenses-$64,953PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$1,273,081CYRevenuesLessExpensesAmt
Total Assets BOY$7,031,609TotalAssetsBOYAmt
Total Assets EOY$6,202,847TotalAssetsEOYAmt
Total Liabilities BOY$930,873TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,059,559TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$6,100,736NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$5,143,288NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionNATIONAL PEDIATRIC CANCER FOUNDATION (NPCF) IS A NONPROFIT ORGANIZATION DEDICATED TO FUNDING RESEARCH TO ELIMINATE CHILDHOOD CANCER. OUR FOCUS IS TO FUND RESEARCH TO FIND LESS TOXIC, MORE TARGETED THERAPIES BY PARTNERING WITH LEADING HOSPITALS NATIONWIDE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$5,120,886ExpenseAmt
Grant$3,441,620GrantAmt
DescTHE NATIONAL PEDIATRIC CANCER FOUNDATION FUNDS PEDIATRIC CANCER RESEARCH WITH THE GOAL OF LEADING TO THE TREATMENT AND ELIMINATION OF PEDIATRIC CANCER WORLDWIDE.WE ACCOMPLISH OUR MISSION THROUGH OUR RESEARCH INITIATIVE, THE SUNSHINE PROJECT, AN INNOVATIVE COLLABORATION OF 40 HOSPITALS NATIONWIDE. THIS COLLABORATIVE RESEARCH MODEL IS UNIQUE AND EFFECTIVE IN ACCELERATING THE DEVELOPMENT OF NEW TREATMENTS AGAINST CHILDHOOD CANCER.SEE SCHEDULE O FOR FURTHER PROGRAM SERVICE ACCOMPLISHMENTS.IN DEVELOPING THIS COLLABORATION, THE FOUNDATION HAS BROUGHT TOGETHER SOME OF THE COUNTRY'S LEADING INVESTIGATORS AND INSTITUTIONS TO DRIVE THE PROCESS OF FINDING A CURE. INVESTIGATORS ARE PERFORMING THREE VITAL PHASES OF RESEARCH SIMULTANEOUSLY: BASIC SCIENCE, TRANSLATIONAL RESEARCH AND CLINICAL TRIALS. THESE MAJOR RESEARCH COMPONENTS NOT ONLY ALLOW DOCTORS TO IDENTIFY NEW AGENTS IN FIGHTING CANCER, BUT ALSO HELP RESEARCHERS TO UNDERSTAND THE CANCER CELLS RESPONSE TO THE DRUG. THE NATIONAL PEDIATRIC CANCER FOUNDATION IS MAKING GREAT STRIDES IN ITS MISSION TO FIND A CURE FOR CHILDHOOD CANCER.CURRENT INITIATIVES OF THE SUNSHINE PROJECT ARE AS FOLLOWS:SARCOMA TRIALS (OSTEOSARCOMA, RHABDOMYOSARCOMA, EWING SARCOMA, NON-RHABDOMYOSARCOMA); BRAIN CANCER TRIALS (MEDULLOBLASTOMA, HIGH-GRADE GLIOMA); SOLID STATE TUMORS1. EVOLUTIONARY INSPIRED THERAPY FOR NEWLY DIAGNOSED, METASTATIC, FUSION POSITIVE RHABDOMYOSARCOMA - METASTATIC, FUSION POSITIVE RHABDOMYOSARCOMA (RMS) HAVE A POOR OUTCOME WHICH IS WORSENED WITH ADDITIONAL RISK FACTORS COMMONLY CALLED THE OBERLIN CRITERIA. PATIENTS THAT MEET ALL 4 OBERLIN CRITERIA HAVE AN EVENT FREE SURVIVAL (EFS) OF LESS THAN 20% AT 2 YEARS. ALL THERAPEUTIC ARMS ON THIS STUDY ARE DESIGNED TO MEET THE SAME PRIMARY AIM OF IMPROVING THE 3-YEAR EVENT FREE SURVIVAL FROM 6% TO 35% FOR THESE PATIENTS. 2. BLOOD BASED BIOMARKERS FOR MINIMAL RESIDUAL DISEASE DETECTION IN PEDIATRIC SARCOMAS - THE PURPOSE OF THIS STUDY IS TO SEE IF DETECTING CELL-FREE PLASMA TUMOR DNA (PTDNA) AND CIRCULATING TUMOR CELLS (CTC) CAN PREDICT RECURRENCE OF DISEASE IN PATIENTS WHO ARE IN RADIOGRAPHIC REMISSION 2-3 WEEKS AFTER TREATMENT. PLASMA TUMOR DNA (PTDNA) IS FREE FLOATING DNA FROM THE TUMOR FOUND IN THE BLOOD STREAM AND CIRCULATING TUMOR CELLS.3. A MULTI-INSTITUTION STUDY OF TGFB IMPRINTED, EX VIVO EXPANDED UNIVERSAL DONOR NK CELL INFUSIONS AS ADOPTIVE IMMUNOTHERAPY IN COMBINATION WITH GEMCITABINE AND DOCETAXEL IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC BONE AND SOFT TISSUE SARCOMAS: THE TINKS TRIAL - THE PURPOSE OF THIS TRIAL IS TO DETERMINE THE SAFETY OF THE ADDITION OF ADOPTIVE TRANSFER OF UNIVERSAL DONOR, TGFB IMPRINTED (TGFBI), EXPANDED NK CELLS TO GEMCITABINE/DOCETAXEL (GEM/DOX) FOR TREATMENT OF RELAPSED AND REFRACTORY SARCOMAS AND TO DETERMINE THE 6 MONTH PROGRESSION FREE SURVIVAL ACHIEVED WITH THIS TREATMENT.4. FEASIBILITY OF GENERATING NOVEL TRANSLATIONAL AND THERAPEUTIC STRATEGIES BASED ON A MULTICENTER, PEDIATRIC AND AYA EVOLUTIONARY TUMOR BOARD (PEDSETB) - PEDIATRIC EVOLUTIONARY TUMOR BOARD (PEDSETB) IS A MULTIDISCIPLINARY FORUM TO APPROACH AN INDIVIDUAL PATIENT'S CANCER AND PROPOSE ADDITIONAL IDEAS FOR CARE. THE PEDSETB WILL GATHER DISCIPLINES NOT OFTEN ENGAGED IN CANCER WORK AND USE INSIGHTS FROM EVOLUTION TO OPTIMALLY MODEL, RESEARCH, AND IMPACT PEDIATRIC CANCER OUTCOMES. STRATEGIES FROM PEDSETB'S PREDECESSOR HAVE BEEN INSTRUMENTAL IN THE DESIGN OF SEVERAL OF NPCF'S MOST RECENT CLINICAL TRIALS5. EVALUATION OF DIGOXIN FOR RELAPSED NON-WNT, NON-SHH MEDULLOBLASTOMA (PHASE 2 STUDY) - THIS TRIAL WILL EVALUATE THE EFFICACY OF DIGOXIN IN TREATING PATIENTS WITH RELAPSED NON-SHH, NON-WNT MEDULLOBLASTOMA AND TO DETERMINE IF DIGOXIN IMPROVES PROGRESSION FREE SURVIVAL AT 4 MONTHS AFTER INITIATION OF STUDY TREATMENT IN THIS PATIENT POPULATION. 6. METASTATIC EWING'S TRIAL TESTING SCHEDULE ENHANCEMENT TO IMPROVE OUTCOMES - THIS TRIAL WILL TEST OUR ABILITY TO ADMINISTER FREQUENTLY CHANGING CHEMOTHERAPY REGIMENS, CALLED SEQUENTIAL SECOND STRIKES, TO PATIENTS WITH WIDELY METASTATIC EWING SARCOMA TO STOP ITS DEVELOPMENT OF RESISTANCE TO CHEMOTHERAPY AND IMPROVE CURE RATES.7. RNA LIPID PARTICLES TARGETING PEDIATRIC RECURRENT INTRACRANIAL MALIGNANCIES AND OTHER SYSTEMIC SOLID TUMORS - THIS TRIAL TESTS THE SAFETY, IMMUNE EFFECTS, AND POTENTIAL EFFECTIVENESS OF RNA-LOADED LIPID NANOPARTICLES (RNA-LP) VACCINES IN PATIENTS WITH RECURRENT PEDIATRIC HIGH-GRADE GLIOMA (PHGG), A TYPE OF BRAIN CANCER, AND RECURRENT OSTEOSARCOMA (OSA), A TYPE OF BONE CANCER. 8. OPEN-LABEL, COHORT-SEQUENTIAL DOSE-ESCALATION AND DOSE-CONFIRMATION PHASE 1-2 CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DOMATINOSTAT IN COMBINATION WITH SIROLIMUS IN ADOLESCENTS AND ADULTS WITH RELAPSED, REFRACTORY SARCOMA AND OSTEOSARCOMA - THIS TRIAL TESTS THE SAFETY AND EFFECTIVENESS OF TWO DRUGS, DOMATINOSTAT AND SIROLIMUS, USED TOGETHER IN PATIENTS WITH OSTEOSARCOMA AND OTHER SARCOMAS THAT HAVE COME BACK OR DON'T RESPOND TO OTHER TREATMENTS. 9. ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3'UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS - THIS STUDY HAS IDENTIFIED A NOVEL TECHNOLOGY THAT CAN CONTROL AND DEGRADE A SPECIFIC C-MYC GENE (KNOWN AS THE MASTER REGULATOR) ACROSS MANY TYPES OF CANCERS. SINCE C-MYC IS DETECTED IN 74% OF HUMAN CANCERS, THE ABILITY TO DEGRADE AND ATTACK THIS COMMON LINK HAS THE POTENTIAL TO TRANSFORM THE TREATMENT OF CANCER. 10. TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOLOGY - THIS STUDY WILL USE QUANTUM MECHANICS TO PRECISELY TARGET SPECIFIC TUMOR CELLS WITHOUT HARMING NORMAL CELLS. THE METHOD USES CONVENTIONAL CLINICAL PROCEDURES IN A NOVEL COMBINATION WITHIN A WEAK MAGNETIC FIELD, AKIN TO A REFRIGERATOR MAGNET'S, SUCH THAT IF SUCCESSFUL IT COULD BE INTRODUCED INTO ANY HOSPITAL WITHOUT MAJOR INFRASTRUCTURAL, FINANCIAL OR PROCEDURAL DIFFICULT TO TREAT CHILDREN AND EVEN INFANTS WITH MEDULLOBLASTOMA, THE MOST COMMON CHILDHOOD BRAIN CANCER.Desc
Total Program Service Expenses$5,120,886TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document58IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee21EmployeeCnt
Employment Tax Returns Filed0EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members22GoverningBodyVotingMembersCnt
Independent Voting Member22IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTXStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL PEDIATRIC CANCER FOUNDATION INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8132690955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15550 WEST EXECUTIVE DRIVE SUITE 200AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33609ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
ALBERT SILVA
CHAIRMAN OF THE BOARD2.00Yes (X)Yes (X)$0$0$0
MICHAEL LEVIN
PAST CHAIR2.00Yes (X)Yes (X)$0$0$0
RICHARD HUFF
VICE CHAIRMAN2.00Yes (X)Yes (X)$0$0$0
ALEX SULLIVAN
VICE CHAIRMAN2.00Yes (X)Yes (X)$0$0$0
JEREMY PERSINGER
TREASURER2.00Yes (X)Yes (X)$0$0$0
JOHN FITZPATRICK
SECRETARY2.00Yes (X)Yes (X)$0$0$0
MICHAEL WEIGNER
ASSISTANT SECRETARY2.00Yes (X)Yes (X)$0$0$0
MELISSA DUNKEL
CO-FOUNDER AT LARGE1.00Yes (X)$0$0$0
JIM BASSIL
DIRECTOR1.00Yes (X)$0$0$0
BB ABBOTT
DIRECTOR1.00Yes (X)$0$0$0
DAVID BOYINGTON
DIRECTOR1.00Yes (X)$0$0$0
CHRIS CARRERE
DIRECTOR AT LARGE1.00Yes (X)$0$0$0
CARRIE CHARLES
DIRECTOR1.00Yes (X)$0$0$0
CHAD HARROD
EMERITUS1.00Yes (X)$0$0$0
JOSEPH LAMPHIER
DIRECTOR1.00Yes (X)$0$0$0
JAY LANGFORD
DIRECTOR1.00Yes (X)$0$0$0
JEFF MAXWELL
DIRECTOR AT LARGE1.00Yes (X)$0$0$0
MARK MCHUGH
DIRECTOR AT LARGE1.00Yes (X)$0$0$0
ANGELA NORTH
DIRECTOR1.00Yes (X)$0$0$0
MARCO SCHNABL
DIRECTOR AT LARGE1.00Yes (X)$0$0$0
DAWN SILER-NIXON
DIRECTOR1.00Yes (X)$0$0$0
ASHLIE TEELING
DIRECTOR1.00Yes (X)$0$0$0
DAVID FRAZER
CEO40.00Yes (X)$210,377$0$0
DAWN ZACHMAN
COO40.00Yes (X)$119,939$0$0
ROBERT MARTIN
CFO THRU OCTOBER 202440.00Yes (X)$132,178$0$0
JENNIFER FINNEMORE
CFO START OCTOBER 202440.00Yes (X)$30,492$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$492,986TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$0TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K3IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Fundraising$861,586FundraisingAmt
All Other Contributions$3,357,881AllOtherContributionsAmt
Noncash Contributions$10,622NoncashContributionsAmt
Total Contributions$4,219,467TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$129,377TotalRevenueColumnAmt
Exclusion$129,377ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$963,645SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$1,005,941SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$42,296SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$42,296TotalRevenueColumnAmt
Exclusion-$42,296ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$1,917,654FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$861,586ContriRptFundraisingEventAmt
Fundraising Direct Expenses$1,782,971FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$134,683TotalRevenueColumnAmt
Exclusion$134,683ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUS REVNEUEDesc
Business900099BusinessCd
Total Revenue Column$8,738TotalRevenueColumnAmt
Exclusion$8,738ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$8,738OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,449,969TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$230,502ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,429,303TotalAmt
Program Services$3,429,303ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$12,317TotalAmt
Program Services$12,317ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$492,986TotalAmt
Program Services$414,454ProgramServicesAmt
Management And General$42,970ManagementAndGeneralAmt
Fundraising$35,562FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,023,485TotalAmt
Program Services$860,446ProgramServicesAmt
Management And General$89,208ManagementAndGeneralAmt
Fundraising$73,831FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$52,634TotalAmt
Program Services$44,249ProgramServicesAmt
Management And General$4,588ManagementAndGeneralAmt
Fundraising$3,797FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$116,472TotalAmt
Program Services$97,918ProgramServicesAmt
Management And General$10,152ManagementAndGeneralAmt
Fundraising$8,402FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$28,270TotalAmt
Management And General$28,270ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$36,032TotalAmt
Program Services$1,566ProgramServicesAmt
Management And General$29,708ManagementAndGeneralAmt
Fundraising$4,758FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$132,228TotalAmt
Program Services$1,207ProgramServicesAmt
Management And General$88ManagementAndGeneralAmt
Fundraising$130,933FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$19,313TotalAmt
Program Services$8,968ProgramServicesAmt
Management And General$5,803ManagementAndGeneralAmt
Fundraising$4,542FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$108,836TotalAmt
Program Services$89,179ProgramServicesAmt
Management And General$12,673ManagementAndGeneralAmt
Fundraising$6,984FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$49,241TotalAmt
Program Services$42,417ProgramServicesAmt
Management And General$3,420ManagementAndGeneralAmt
Fundraising$3,404FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$17,857TotalAmt
Program Services$2,500ProgramServicesAmt
Management And General$3,807ManagementAndGeneralAmt
Fundraising$11,550FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,623TotalAmt
Program Services$117ProgramServicesAmt
Management And General$351ManagementAndGeneralAmt
Fundraising$1,155FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$28,378TotalAmt
Program Services$24,984ProgramServicesAmt
Management And General$1,677ManagementAndGeneralAmt
Fundraising$1,717FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$52,167TotalAmt
Program Services$45,961ProgramServicesAmt
Management And General$3,121ManagementAndGeneralAmt
Fundraising$3,085FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$31,415TotalAmt
Program Services$24,845ProgramServicesAmt
Management And General$4,859ManagementAndGeneralAmt
Fundraising$1,711FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
ONLINE TRANSACTION FEES$44,788$0$3,154$41,634
POSTAGE AND SHIPPING$27,022$5,864$656$20,502
CONTRACT LABOR$12,583$11,070$771$742
PRINTING AND REPRODUCTI$4,092$3,521$336$235

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,008TotalAmt
Management And General$532ManagementAndGeneralAmt
Fundraising$1,476FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$5,723,050TotalAmt
Program Services$5,120,886ProgramServicesAmt
Management And General$246,144ManagementAndGeneralAmt
Fundraising$356,020FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,273,888BOYAmt
EOY$581,005EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
EOY$602,727EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$32,475BOYAmt
EOY$21,455EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$193,136BOYAmt
EOY$134,416EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,692,819LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$178,174LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,510,693BOYAmt
EOY$1,514,645EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$3,750,447BOYAmt
EOY$3,050,583EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$270,970BOYAmt
EOY$298,016EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$7,031,609BOYAmt
EOY$6,202,847EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$76,027BOYAmt
EOY$126,715EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
EOY$272,704EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$189,597BOYAmt
EOY$37,743EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$647,870BOYAmt
EOY$608,148EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$17,379BOYAmt
EOY$14,249EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$930,873BOYAmt
EOY$1,059,559EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,418,356BOYAmt
EOY$4,475,544EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$682,380BOYAmt
EOY$667,744EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$6,100,736BOYAmt
EOY$5,143,288EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$7,031,609BOYAmt
EOY$6,202,847EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$1,273,081ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$315,633NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,078,949CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,578,042CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,041,195CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,886,542CurrentTaxYearMinus1YearAmt
Current Tax Year$4,219,467CurrentTaxYearAmt
Total$18,804,195TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,078,949CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,578,042CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,041,195CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,886,542CurrentTaxYearMinus1YearAmt
Current Tax Year$4,219,467CurrentTaxYearAmt
Total$18,804,195TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$1,705,946SubstantialContributorsTotAmt
Public Support Total170$17,098,249PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$958,567CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$99,773CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$128,799CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$161,711CurrentTaxYearMinus1YearAmt
Current Tax Year$129,377CurrentTaxYearAmt
Total$1,478,227TotalAmt
FieldValueIRS element (for citing)
Total Support$20,282,422TotalSupportAmt
Gross Receipts Rltd Activities$3,534,561GrossReceiptsRltdActivitiesAmt
Public Support CY1700.84300PublicSupportCY170Pct
Public Support PY1700.83730PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Agent Trustee Etc0AgentTrusteeEtcInd

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$2,347,526BeginningYearBalanceAmt
Contributions$3,916ContributionsAmt
Investment Earnings Or Losses$240,668InvestmentEarningsOrLossesAmt
End Year Balance$2,592,110EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$2,097,998BeginningYearBalanceAmt
Contributions$28,104ContributionsAmt
Investment Earnings Or Losses$221,424InvestmentEarningsOrLossesAmt
End Year Balance$2,347,526EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,904,761BeginningYearBalanceAmt
Contributions$30,479ContributionsAmt
Investment Earnings Or Losses$162,758InvestmentEarningsOrLossesAmt
End Year Balance$2,097,998EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$2,194,890BeginningYearBalanceAmt
Contributions$25,172ContributionsAmt
Investment Earnings Or Losses-$315,301InvestmentEarningsOrLossesAmt
End Year Balance$1,904,761EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,013,600BeginningYearBalanceAmt
Contributions$883,542ContributionsAmt
Investment Earnings Or Losses$297,748InvestmentEarningsOrLossesAmt
End Year Balance$2,194,890EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.88000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.03000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.09000TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,545,000OtherCostOrOtherBasisAmt
Depreciation$117,545DepreciationAmt
Book Value$1,427,455BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$147,819OtherCostOrOtherBasisAmt
Depreciation$60,629DepreciationAmt
Book Value$87,190BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$1,514,645TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescFINANCING LEASE PAYABLEDesc
Amt$14,249Amt
FieldValueIRS element (for citing)
Total Liability$14,249TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$4,748,979TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$315,633NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$11,647DonatedServicesAndUseFcltsAmt
Revenue Not Reported$327,280RevenueNotReportedAmt
Revenue Subtotal$4,421,699RevenueSubtotalAmt
Investment Expenses Not Incld$28,270InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$28,270RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$4,449,969TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$5,706,427TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$11,647DonatedServicesUseFcltsAmt
Expenses Not Reported$11,647ExpensesNotReportedAmt
Expenses Subtotal$5,694,780ExpensesSubtotalAmt
Investment Expenses Not Incld2$28,270InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$28,270ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$5,723,050TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:THE FOUNDATION HAS RECEIVED A DETERMINATION OF TAX EXEMPT STATUS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS REFLECTED IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT IS NOT AWARE OF ANY ACTIVITIES THAT WOULD JEOPARDIZE THE FOUNDATION'S TAX EXEMPT STATUS. THE FOUNDATION IS NOT AWARE OF ANY TAX POSITIONS IT HAS TAKEN THAT ARE SUBJECT TO A SIGNIFICANT DEGREE OF UNCERTAINTY. TAX YEARS AFTER JUNE 30, 2021 REMAIN SUBJECT TO EXAMINATION BY TAXING AUTHORITIES.
PART V, LINE 4:THE NATIONAL PEDIATRIC CANCER FOUNDATION MAINTAINS AN ENDOWMENT FUND AT THE COMMUNITY FOUNDATION OF TAMPA BAY, INC. FOR THE LONG TERM BENEFIT OF THE NATIONAL PEDIATRIC CANCER FOUNDATION.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1FASHION FUNDS THE CUREEvent1Nm
Gross Receipts Event1$1,839,959GrossReceiptsEvent1Amt
Charitable Contri Event1$726,238CharitableContriEvent1Amt
Gross Revenue Event1$1,113,721GrossRevenueEvent1Amt
Rent Facility Costs Event1$37,500RentFacilityCostsEvent1Amt
Other Direct Expenses Event1$957,861OtherDirectExpensesEvent1Amt
Event2FISHING FUNDS THE CUREEvent2Nm
Gross Receipts Event2$563,749GrossReceiptsEvent2Amt
Charitable Contri Event2$81,345CharitableContriEvent2Amt
Gross Revenue Event2$482,404GrossRevenueEvent2Amt
Rent Facility Costs Event2$1,305RentFacilityCostsEvent2Amt
Other Direct Expenses Event2$429,010OtherDirectExpensesEvent2Amt
Other Events Total8OtherEventsTotalCnt
Gross Receipts Other Events$375,532GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$54,003CharitableContriOtherEventsAmt
Gross Revenue Other Events$321,529GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$17,300RentFcltyCostsOtherEventsAmt
Oth Direct Expnss Other Events$339,995OthDirectExpnssOtherEventsAmt
Gross Receipts Total$2,779,240GrossReceiptsTotalAmt
Charitable Contributions Tot$861,586CharitableContributionsTotAmt
Gross Revenue Total Events$1,917,654GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$56,105RentFcltyCostsTotalEventsAmt
Oth Direct Expnss Total Events$1,726,866OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$1,782,971DirectExpenseSummaryEventsAmt
Net Income Summary$134,683NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (15 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC
12902 MAGNOLIA DRIVETAMPAFL33612593238636501(C)(3)$110,000$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE
12902 MAGNOLIA DRIVETAMPAFL33612592451713501(C)(3)$657,764$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY10461472209056501(C)(3)$713,110$0FOR 43 CHALLENGE PROJECT - ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS AND ONE CARON META IN EWING SARCOMA TRIAL
UNIVERSITY OF FLORIDA
PO BOX 115500GAINESVILLEFL32611596002052501(C)(3)$64,417$0IN SUPPORT OF CLINICAL TRIAL ADVANCING INKT STUDY
UNIVERSITY OF COLORADO
MS F428 AMC BLDG 500AURORACO80045846000555501(C)(3)$91,654$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
CONNECTICUT CHILDREN'S MEDICAL CENTER
282 WASHINGTON STHARTFORDCT06106232619869501(C)(3)$40,856$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
DUKE UNIVERSITY
PO BOX 104132DURHAMNC27708560532129501(C)(3)$37,118$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVE SUITE 700NASHVILLETN37203352528741501(C)(3)$37,964$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200CHAPEL HILLNC27599566001393501(C)(3)$102,500$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVECLEVELANDOH44195340714585501(C)(3)$192,451$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
PO BOX 781653DETROITMI48278311036372501(C)(3)$992,092$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
10889 WILSHIRE BLVD SUITE 700LOS ANGELESCA90095943067788501(C)(3)$200,000$0FOR 43 CHALLENGE PROJECT - TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOBIOLOGY
BAYCARE ST JOSEPH'S HOSPITAL INC
2985 DREW STCLEARWATERFL33579590774199501(C)(3)$44,306$0IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
JOHN HOPKINS UNIVERSITY
1800 ORLEANS STREET BLOOMBERG 11NBALTIMOREMD21287520595110501(C)(3)$50,000$0IN SUPPORT OF CLINICAL TRIAL ADVANCING RHABDOMYOSARCOMA RESEARCH
CHILDREN'S RESEARCH INSTITUTE
1 INVENTA PLACE WEST TOWER 3RDSILVER SPRINGMD20910521640402501(C)(3)$95,071$0IN SUPORT OF INKT TRIAL CONDUCTED UNDER THE SUNSHINE PROJECTFLOOR

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

FieldValueIRS element (for citing)
Grant TypeSAFETY NET GRANT FOR REIMBURSABLE MEDICAL EXPENSES NOT COVERED BY INSURANCEGrantTypeTxt
Recipient12RecipientCnt
Cash Grant$12,317CashGrantAmt
Valuation Method UsedFMVValuationMethodUsedDesc

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Written Employment ContractYes (X)WrittenEmploymentContractInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp

FieldValueIRS element (for citing)
PersonDAVID FRAZERPersonNm
TitleCEOTitleTxt
Base Compensation Filing Org$191,783BaseCompensationFilingOrgAmt
Compensation Based On Rltd Orgs$0CompensationBasedOnRltdOrgsAmt
Bonus Filing Organization$18,594BonusFilingOrganizationAmount
Bonus Related Organizations$0BonusRelatedOrganizationsAmt
Other Compensation Filing Org$0OtherCompensationFilingOrgAmt
Other Compensation Rltd Orgs$0OtherCompensationRltdOrgsAmt
Deferred Compensation Flng Org$0DeferredCompensationFlngOrgAmt
Deferred Comp Rltd Orgs$0DeferredCompRltdOrgsAmt
Nontaxable Benefits Filing Org$0NontaxableBenefitsFilingOrgAmt
Nontaxable Benefits Rltd Orgs$0NontaxableBenefitsRltdOrgsAmt
Total Compensation Filing Org$210,377TotalCompensationFilingOrgAmt
Total Compensation Rltd Orgs$0TotalCompensationRltdOrgsAmt
Comp Report Prior990 Filing Org$0CompReportPrior990FilingOrgAmt
Comp Report Prior990 Rltd Orgs$0CompReportPrior990RltdOrgsAmt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BTHE BOARD OF DIRECTORS RECEIVES THE DRAFT OF THE FORM 990 AND APPROVES THE FORM 990 PRIOR TO THE FORM BEING FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CTHE FOUNDATION'S CONFLICT OF INTEREST POLICY IS DISCUSSED AT ORIENTATION OF OFFICERS AND DIRECTORS ON A PERIODIC BASIS, AT LEAST ANNUALLY.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION FOR THE CEO AND OTHER KEY EMPLOYEES IS REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AND BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION C, LINE 19THE NATIONAL PEDIATRIC CANCER FOUNDATION MAKES ITS GOVERNING DOCUMENTS, PRIVACY POLICY AND FINANCIAL INFORMATION AVAILABLE FOR PUBLIC INSPECTION THROUGH THE ORGANIZATION'S WEBSITE AS WELL AS UPON REQUEST.
FORM 990, PART XII, LINE 2C, FINANCIAL STATEMENTS AND REPORTINGTHE PROCESS FOR OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT HAS NOT CHANGED FROM THE PRIOR YEAR.